Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Macrophage Activation Marker Soluble CD163 Associated with Fatal and Severe Ebola Virus Disease in Humans1.

McElroy AK, Shrivastava-Ranjan P, Harmon JR, Martines RB, Silva-Flannery L, Flietstra TD, Kraft CS, Mehta AK, Lyon GM, Varkey JB, Ribner BS, Nichol ST, Zaki SR, Spiropoulou CF.

Emerg Infect Dis. 2019 Feb;25(2):290-298. doi: 10.3201/eid2502.181326.

2.

New Lineage of Lassa Virus, Togo, 2016.

Whitmer SLM, Strecker T, Cadar D, Dienes HP, Faber K, Patel K, Brown SM, Davis WG, Klena JD, Rollin PE, Schmidt-Chanasit J, Fichet-Calvet E, Noack B, Emmerich P, Rieger T, Wolff S, Fehling SK, Eickmann M, Mengel JP, Schultze T, Hain T, Ampofo W, Bonney K, Aryeequaye JND, Ribner B, Varkey JB, Mehta AK, Lyon GM 3rd, Kann G, De Leuw P, Schuettfort G, Stephan C, Wieland U, Fries JWU, Kochanek M, Kraft CS, Wolf T, Nichol ST, Becker S, Ströher U, Günther S.

Emerg Infect Dis. 2018 Mar;24(3):599-602. doi: 10.3201/eid2403.171905.

3.

Favipiravir and Ribavirin Treatment of Epidemiologically Linked Cases of Lassa Fever.

Raabe VN, Kann G, Ribner BS, Morales A, Varkey JB, Mehta AK, Lyon GM, Vanairsdale S, Faber K, Becker S, Eickmann M, Strecker T, Brown S, Patel K, De Leuw P, Schuettfort G, Stephan C, Rabenau H, Klena JD, Rollin PE, McElroy A, Ströher U, Nichol S, Kraft CS, Wolf T; Emory Serious Communicable Diseases Unit.

Clin Infect Dis. 2017 Sep 1;65(5):855-859. doi: 10.1093/cid/cix406.

4.

A Case of Human Lassa Virus Infection With Robust Acute T-Cell Activation and Long-Term Virus-Specific T-Cell Responses.

McElroy AK, Akondy RS, Harmon JR, Ellebedy AH, Cannon D, Klena JD, Sidney J, Sette A, Mehta AK, Kraft CS, Lyon MG, Varkey JB, Ribner BS, Nichol ST, Spiropoulou CF.

J Infect Dis. 2017 Jun 15;215(12):1862-1872. doi: 10.1093/infdis/jix201.

5.

Long-term Management of Panuveitis and Iris Heterochromia in an Ebola Survivor.

Shantha JG, Crozier I, Varkey JB, Kraft CS, Lyon GM 3rd, Mehta AK, Carlson RD, Hill CE, Kumar G, Debiec MR, Patel PS, Olsen TW, Nussenblatt RB, Martin DF, Ströher U, Uyeki TM, Ribner BS, Smith JR, Yeh S.

Ophthalmology. 2016 Dec;123(12):2626-2628.e2. doi: 10.1016/j.ophtha.2016.07.013. Epub 2016 Sep 1. No abstract available.

6.

Kinetic Analysis of Biomarkers in a Cohort of US Patients With Ebola Virus Disease.

McElroy AK, Harmon JR, Flietstra TD, Campbell S, Mehta AK, Kraft CS, Lyon MG, Varkey JB, Ribner BS, Kratochvil CJ, Iwen PC, Smith PW, Ahmed R, Nichol ST, Spiropoulou CF.

Clin Infect Dis. 2016 Aug 15;63(4):460-7. doi: 10.1093/cid/ciw334. Epub 2016 Jun 27. Erratum in: Clin Infect Dis. 2017 Aug 15;65(4):706.

7.

Preparing for Serious Communicable Diseases in the United States: What the Ebola Virus Epidemic Has Taught Us.

Varkey JB, Ribner BS.

Microbiol Spectr. 2016 Jun;4(3). doi: 10.1128/microbiolspec.EI10-0011-2016.

8.

Ebola Virus Persistence in Semen of Male Survivors.

Uyeki TM, Erickson BR, Brown S, McElroy AK, Cannon D, Gibbons A, Sealy T, Kainulainen MH, Schuh AJ, Kraft CS, Mehta AK, Lyon GM 3rd, Varkey JB, Ribner BS, Ellison RT 3rd, Carmody E, Nau GJ, Spiropoulou C, Nichol ST, Ströher U.

Clin Infect Dis. 2016 Jun 15;62(12):1552-1555. doi: 10.1093/cid/ciw202. Epub 2016 Apr 3.

PMID:
27045122
9.

Persistent Ebola Virus in the Eye.

Yeh S, Varkey JB, Crozier I.

N Engl J Med. 2015 Nov 12;373(20):1982-3. doi: 10.1056/NEJMc1510459. No abstract available.

PMID:
26559587
10.

Comparison of FilmArray and Quantitative Real-Time Reverse Transcriptase PCR for Detection of Zaire Ebolavirus from Contrived and Clinical Specimens.

Southern TR, Racsa LD, Albariño CG, Fey PD, Hinrichs SH, Murphy CN, Herrera VL, Sambol AR, Hill CE, Ryan EL, Kraft CS, Campbell S, Sealy TK, Schuh A, Ritchie JC, Lyon GM 3rd, Mehta AK, Varkey JB, Ribner BS, Brantly KP, Ströher U, Iwen PC, Burd EM.

J Clin Microbiol. 2015 Sep;53(9):2956-60. doi: 10.1128/JCM.01317-15. Epub 2015 Jul 8.

11.

Ebola virus disease: preparedness and infection control lessons learned from two biocontainment units.

Hewlett AL, Varkey JB, Smith PW, Ribner BS.

Curr Opin Infect Dis. 2015 Aug;28(4):343-8. doi: 10.1097/QCO.0000000000000176. Review.

12.

Characteristics and Clinical Management of a Cluster of 3 Patients With Ebola Virus Disease, Including the First Domestically Acquired Cases in the United States.

Liddell AM, Davey RT Jr, Mehta AK, Varkey JB, Kraft CS, Tseggay GK, Badidi O, Faust AC, Brown KV, Suffredini AF, Barrett K, Wolcott MJ, Marconi VC, Lyon GM 3rd, Weinstein GL, Weinmeister K, Sutton S, Hazbun M, Albariño CG, Reed Z, Cannon D, Ströher U, Feldman M, Ribner BS, Lane HC, Fauci AS, Uyeki TM.

Ann Intern Med. 2015 Jul 21;163(2):81-90. doi: 10.7326/M15-0530.

13.

Persistence of Ebola Virus in Ocular Fluid during Convalescence.

Varkey JB, Shantha JG, Crozier I, Kraft CS, Lyon GM, Mehta AK, Kumar G, Smith JR, Kainulainen MH, Whitmer S, Ströher U, Uyeki TM, Ribner BS, Yeh S.

N Engl J Med. 2015 Jun 18;372(25):2423-7. doi: 10.1056/NEJMoa1500306. Epub 2015 May 7. Erratum in: N Engl J Med. 2015 Jun 18;372(25):2469.

14.

Antibiotic use in US hospitals: quantification, quality measures and stewardship.

Reddy SC, Jacob JT, Varkey JB, Gaynes RP.

Expert Rev Anti Infect Ther. 2015 Jul;13(7):843-54. doi: 10.1586/14787210.2015.1040766. Epub 2015 Apr 30. Review.

PMID:
25925531
15.

The Use of TKM-100802 and Convalescent Plasma in 2 Patients With Ebola Virus Disease in the United States.

Kraft CS, Hewlett AL, Koepsell S, Winkler AM, Kratochvil CJ, Larson L, Varkey JB, Mehta AK, Lyon GM 3rd, Friedman-Moraco RJ, Marconi VC, Hill CE, Sullivan JN, Johnson DW, Lisco SJ, Mulligan MJ, Uyeki TM, McElroy AK, Sealy T, Campbell S, Spiropoulou C, Ströher U, Crozier I, Sacra R, Connor MJ Jr, Sueblinvong V, Franch HA, Smith PW, Ribner BS; Nebraska Biocontainment Unit and the Emory Serious Communicable Diseases Unit.

Clin Infect Dis. 2015 Aug 15;61(4):496-502. doi: 10.1093/cid/civ334. Epub 2015 Apr 22.

16.

Treatment of Ebola.

Mehta AK, Lyon GM, Varkey JB.

N Engl J Med. 2015 Apr 23;372(17):1674. doi: 10.1056/NEJMc1500452. No abstract available.

PMID:
25901439
17.

Fecal microbiota transplant protocol for clostridium difficile infection.

Tauxe WM, Dhere T, Ward A, Racsa LD, Varkey JB, Kraft CS.

Lab Med. 2015 Winter;46(1):e19-23. doi: 10.1309/LMCI95M0TWPDZKOD.

18.

Successful delivery of RRT in Ebola virus disease.

Connor MJ Jr, Kraft C, Mehta AK, Varkey JB, Lyon GM, Crozier I, Ströher U, Ribner BS, Franch HA.

J Am Soc Nephrol. 2015 Jan;26(1):31-7. doi: 10.1681/ASN.2014111057. Epub 2014 Nov 14.

19.

Clinical care of two patients with Ebola virus disease in the United States.

Lyon GM, Mehta AK, Varkey JB, Brantly K, Plyler L, McElroy AK, Kraft CS, Towner JS, Spiropoulou C, Ströher U, Uyeki TM, Ribner BS; Emory Serious Communicable Diseases Unit.

N Engl J Med. 2014 Dec 18;371(25):2402-9. doi: 10.1056/NEJMoa1409838. Epub 2014 Nov 12.

20.

Temporal dynamics of host molecular responses differentiate symptomatic and asymptomatic influenza a infection.

Huang Y, Zaas AK, Rao A, Dobigeon N, Woolf PJ, Veldman T, Øien NC, McClain MT, Varkey JB, Nicholson B, Carin L, Kingsmore S, Woods CW, Ginsburg GS, Hero AO 3rd.

PLoS Genet. 2011 Aug;7(8):e1002234. doi: 10.1371/journal.pgen.1002234. Epub 2011 Aug 25.

21.

Prophylactic vaccinations in chronic obstructive pulmonary disease: current status.

Varkey JB, Varkey AB, Varkey B.

Curr Opin Pulm Med. 2009 Mar;15(2):90-9. doi: 10.1097/MCP.0b013e3283218356. Review.

PMID:
19532022
22.

Pharmacokinetics of posaconazole administered orally or by nasogastric tube in healthy volunteers.

Dodds Ashley ES, Varkey JB, Krishna G, Vickery D, Ma L, Yu X, Malavade D, Goodwin M, Perfect JR, Power E.

Antimicrob Agents Chemother. 2009 Jul;53(7):2960-4. doi: 10.1128/AAC.01178-08. Epub 2009 May 11.

23.

Analysis of two- and three-year trends in antimicrobial resistance in intensive care units using unit-specific antibiograms.

Lalani T, Varkey JB, Drew R, Harrell L, McGarry S, Engemann JG, Johnson MD, Kaye KS.

Scand J Infect Dis. 2008;40(8):672-4.

PMID:
18979607
24.

Preventing surgical site infections in the era of methicillin-resistant Staphylococcus aureus.

Varkey JB, Anderson DJ, Kaye KS.

Curr Infect Dis Rep. 2008 Sep;10(5):341-2. No abstract available.

PMID:
18687193
25.

Rare and emerging fungal pulmonary infections.

Varkey JB, Perfect JR.

Semin Respir Crit Care Med. 2008 Apr;29(2):121-31. doi: 10.1055/s-2008-1063851. Review.

PMID:
18365994
26.

Viral infections in patients with chronic obstructive pulmonary disease.

Varkey JB, Varkey B.

Curr Opin Pulm Med. 2008 Mar;14(2):89-94. doi: 10.1097/MCP.0b013e3282f4a99f. Review.

PMID:
18303415
27.

Non-O1 Vibrio cholerae septicemia: case report, discussion of literature, and relevance to bioterrorism.

Anderson AM, Varkey JB, Petti CA, Liddle RA, Frothingham R, Woods CW.

Diagn Microbiol Infect Dis. 2004 Aug;49(4):295-7.

PMID:
15313536

Supplemental Content

Loading ...
Support Center